Conexiant’s news site is now MDSpire News. Learn more
Advertisement
CREST-2 Findings Highlight Evolving Role of Carotid Artery Stenting
New findings from CREST-2 are providing important evidence on the role of carotid artery stenting (CAS) in patients with severe asymptomatic carotid stenosis — while underscoring the importance of operator experience, patient selection and procedural technique in achieving favorable outcomes.
Clinical Report: CREST-2 Findings Highlight Evolving Role of Carotid Artery Stenting
Overview
The CREST-2 trial provides evidence supporting carotid artery stenting (CAS) in patients with severe asymptomatic carotid stenosis. The study found a lower stroke rate in patients receiving CAS combined with intensive medical management compared to those receiving medical management alone.
Background
Carotid artery stenosis is a significant risk factor for stroke, making effective management crucial. The role of CAS in conjunction with intensive medical therapy is being evaluated in the context of treatment strategies for asymptomatic patients.
Data Highlights
Group
Stroke/Death Rate
CAS + Medical Therapy
2.8%
Medical Therapy Alone
6.0%
CEA + Medical Therapy
3.7%
Medical Therapy Alone (Endarterectomy)
5.3%
Key Findings
CAS combined with intensive medical management resulted in a 2.8% stroke/death rate at four years.
Medical management alone had a 6.0% stroke/death rate, indicating a significant difference (p=0.02).
Operator experience and careful patient selection were critical to achieving favorable outcomes.
Only 9% of operators were approved on the first review of their credentialing submissions.
Standardized procedural techniques were emphasized, including dual antiplatelet therapy and embolic protection.
Clinical Implications
Clinicians should consider operator experience and patient selection when determining treatment strategies for patients with severe asymptomatic carotid stenosis.
Conclusion
CREST-2 provides insights into the role of CAS in specific patient populations, emphasizing the importance of operator experience and procedural techniques.
Baptist Health will bring together leading physicians, researchers and healthcare professionals from South Florida and across the country for the 14th Annual Baptist Health Miami Neuroscience Symposium, taking place Nov. 4-6, 2026, at Hilton Miami Dadeland and virtually via Zoom.